South Korea’s Second-Richest Man Adds $2.2 Billion To His Wealth While Battling The Coronavirus Pandemic Seo Jung-jin’s Celltrion is on track to start human trials of its coronavirus drug in July. Its shares surged 37.6% since March 18, fueled by optimism for its COVID-19 testing kits and treatments.